Thus, we provided the first demonstration of genome-wide changes in the OCT4-regulated transcriptional network in response to treatment with an epigenetic inhibitor in combination with IR in pancreatic cancer cells, on the basis of RNA-seq technology. Here, POU5F1 is linked to familial pancreatic carcinoma.